Reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) with fludarabine, busulphan and alemtuzumab (CAMPATH-1H) conditioning: Patterns of CD3 and CD15 engraftment, loss of donor T-cells cells predicts decline in donor myeloid engraftment.

A Y L Ho; L Pearce; N Westwood; R Padua; M Kenyon; S Devereux; A Pagliuca; G J Mufti

Reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) with fludarabine, busulphan and alemtuzumab (CAMPATH-1H) conditioning: Patterns of CD3 and CD15 engraftment, loss of donor T-cells cells predicts decline in donor myeloid engraftment.

A Y L Ho, L Pearce, N Westwood, R Padua, M Kenyon, S Devereux, A Pagliuca, G J Mufti

King's College London

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	5459
Number of pages	1
Journal	Blood
Volume	102
Issue number	11
Publication status	Published - 2003
Event	45th Annual Meeting of the American-Society-of-Hematology - SAN DIEGO, CALIFORNIA Duration: 1 Jan 2003 → …

Cite this

Ho, A. Y. L., Pearce, L., Westwood, N., Padua, R., Kenyon, M., Devereux, S., Pagliuca, A., & Mufti, G. J. (2003). Reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) with fludarabine, busulphan and alemtuzumab (CAMPATH-1H) conditioning: Patterns of CD3 and CD15 engraftment, loss of donor T-cells cells predicts decline in donor myeloid engraftment. Blood, 102(11), 5459.

@article{7aa917d295124f1bb4be96cfdcee6542,

title = "Reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) with fludarabine, busulphan and alemtuzumab (CAMPATH-1H) conditioning: Patterns of CD3 and CD15 engraftment, loss of donor T-cells cells predicts decline in donor myeloid engraftment.",

author = "Ho, {A Y L} and L Pearce and N Westwood and R Padua and M Kenyon and S Devereux and A Pagliuca and Mufti, {G J}",

year = "2003",

language = "English",

volume = "102",

pages = "5459",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

number = "11",

note = "45th Annual Meeting of the American-Society-of-Hematology ; Conference date: 01-01-2003",

}

Ho, AYL, Pearce, L, Westwood, N, Padua, R, Kenyon, M, Devereux, S, Pagliuca, A & Mufti, GJ 2003, 'Reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) with fludarabine, busulphan and alemtuzumab (CAMPATH-1H) conditioning: Patterns of CD3 and CD15 engraftment, loss of donor T-cells cells predicts decline in donor myeloid engraftment.', Blood, vol. 102, no. 11, pp. 5459.

Reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) with fludarabine, busulphan and alemtuzumab (CAMPATH-1H) conditioning: Patterns of CD3 and CD15 engraftment, loss of donor T-cells cells predicts decline in donor myeloid engraftment. / Ho, A Y L; Pearce, L; Westwood, N et al.
In: Blood, Vol. 102, No. 11, 2003, p. 5459.

Research output: Contribution to journal › Meeting abstract

TY - JOUR

T1 - Reduced-intensity allogeneic haematopoietic stem cell transplantation (HSCT) with fludarabine, busulphan and alemtuzumab (CAMPATH-1H) conditioning: Patterns of CD3 and CD15 engraftment, loss of donor T-cells cells predicts decline in donor myeloid engraftment.

AU - Ho, A Y L

AU - Pearce, L

AU - Westwood, N

AU - Padua, R

AU - Kenyon, M

AU - Devereux, S

AU - Pagliuca, A

AU - Mufti, G J

PY - 2003

Y1 - 2003

M3 - Meeting abstract

SN - 1528-0020

VL - 102

SP - 5459

JO - Blood

JF - Blood

IS - 11

T2 - 45th Annual Meeting of the American-Society-of-Hematology

Y2 - 1 January 2003

ER -